These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22877873)

  • 1. Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
    Garrido R; Puyada A; Fernández A; González M; Ramírez U; Cardoso F; Valdés Y; González D; Fernández V; Vérez V; Vélez H
    J Pharm Biomed Anal; 2012 Nov; 70():295-300. PubMed ID: 22877873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
    Xie O; Bolgiano B; Gao F; Lockyer K; Swann C; Jones C; Delrieu I; Njanpop-Lafourcade BM; Tamekloe TA; Pollard AJ; Norheim G
    Vaccine; 2012 Aug; 30(40):5812-23. PubMed ID: 22835740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase.
    Muindi KM; McCarthy PC; Wang T; Vionnet J; Battistel M; Jankowska E; Vann WF
    Glycobiology; 2014 Feb; 24(2):139-49. PubMed ID: 24134880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
    Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
    Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production.
    Lemercinier X; Jones C
    Carbohydr Res; 1996 Dec; 296():83-96. PubMed ID: 9008844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of capsular polysaccharide from Neisseria meningitidis serogroup C by liquid chromatography.
    Pato TP; Barbosa Ade P; da Silva Junior JG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):262-7. PubMed ID: 16469547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy.
    Gudlavalleti SK; Szymanski CM; Jarrell HC; Stephens DS
    Carbohydr Res; 2006 Mar; 341(4):557-62. PubMed ID: 16406275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of structures corresponding to the capsular polysaccharide of Neisseria meningitidis group A.
    Slättegård R; Teodorovic P; Kinfe HH; Ravenscroft N; Gammon DW; Oscarson S
    Org Biomol Chem; 2005 Oct; 3(20):3782-7. PubMed ID: 16211114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational studies of the capsular polysaccharide produced by Neisseria meningitidis group A.
    Foschiatti M; Hearshaw M; Cescutti P; Ravenscroft N; Rizzo R
    Carbohydr Res; 2009 May; 344(7):940-3. PubMed ID: 19306991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development.
    Fiebig T; Berti F; Freiberger F; Pinto V; Claus H; Romano MR; Proietti D; Brogioni B; Stummeyer K; Berger M; Vogel U; Costantino P; Gerardy-Schahn R
    Glycobiology; 2014 Feb; 24(2):150-8. PubMed ID: 24259400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of meningococcal disease and the impact of vaccines.
    Khatami A; Pollard AJ
    Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development.
    Hlozek J; Ravenscroft N; Kuttel MM
    Carbohydr Res; 2019 Dec; 486():107838. PubMed ID: 31654945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.